DHA in infants
This article was originally published in The Tan Sheet
Executive Summary
Supplementation of docosahexaenoic acid (DHA) in breastfeeding mothers leads to improved psychomotor skills in infants at 30 months of age, according to a study by Craig Jensen, MD, Baylor College of Medicine, et al., published in the July American Journal of Clinical Nutrition. The double-blind, placebo-controlled study included 227 breastfeeding mothers given 200 mg DHA or placebo daily for four months. DHA supplementation led to higher infant plasma phospholipid DHA content as well as a higher Bayley Psychomotor Development Index at 30 months, "but results in no other advantages either at or before this age," the study concludes...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.